Cidara Therapeutics's market cap is currently $2.45B. The company's EPS TTM is $-1.65; its P/E ratio is ―; Cidara Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-1.39. See an overview of income statement, balance sheet, and cash flow financials.
